RxSight, Inc. RXST shares ended the last trading session 14.1% higher at $10.09. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 30% loss over the past four weeks.
RxSight scored a strong price increase, driven by investor optimism surrounding the release of its preliminary unaudited financial and operational results for the fourth quarter and full-year 2025. The company also announced that veteran Mark Wilterding has been appointed Chief Financial Officer, effective January 11, 2026.
This company is expected to post quarterly loss of $0.25 per share in its upcoming report, which represents a year-over-year change of -933.3%. Revenues are expected to be $26.91 million, down 33.1% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For RxSight, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on RXST going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
RxSight is part of the Zacks Medical - Instruments industry. IDEXX Laboratories IDXX, another stock in the same industry, closed the last trading session 1.6% higher at $724.76. IDXX has returned 1.3% in the past month.
For Idexx, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $2.93. This represents a change of +11.8% from what the company reported a year ago. Idexx currently has a Zacks Rank of #2 (Buy).
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.
Free: See Our Top Stock And 4 Runners UpRxSight, Inc. (RXST) : Free Stock Analysis Report
IDEXX Laboratories, Inc. (IDXX) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
